Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population

Pharmacogenetics and Genomics

Volumn 19, Issue 4, 2009, Pages 310-318

  Lin, Rong ^a   Weng, Ying ^b   Wang, Yi ^a   Fu, Wenqing ^a   Zhang, Dandan ^a   Zheng, Hongxiang ^a   Yu, Ting ^a   Wng, Ying ^b   Shen, Min ^b   Lei, Rong ^b   Wu, Hong ^e   Sun, Aijun ^f   Zhang, Ruifang ^a   Wang, Xiaofeng ^a   Xiong, Momiao ^g   Huang, Wei ^b   Jin, Li ^a,c,d  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d China Medical City Institute of Health Sciences   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

Association study; Bilirubin; Coronary artery disease; Sex difference

Indexed keywords

ADENINE; BILIRUBIN; BILIVERDIN; GLYCOSYLTRANSFERASE; GUANINE; HEME OXYGENASE 1; ORGANIC ANION TRANSPORTER 2; THYMINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1A1;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; BLVRA GENE; CHINA; CHINESE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOMINANT INHERITANCE; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HMOX1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLCO1B1 GENE; UGT1A1 GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HEME OXYGENASE-1; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; ORGANIC ANION TRANSPORTERS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 63849300402     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328328f818     Document Type: Article

References (44)

1. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vase Biol 2005; 25:29-38.
2. Stacker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84:1381-1478.
3. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000; 46:1723-1727.
4. Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, et al. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 2005; 25:2289-2294.
5. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 2001; 154:747-754.
6. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002; 160:449-456.
7. Endler G, Hamwi A, Sunder-Plassmann R, Exner M, Vukovich T, Mannhalter C, et al. Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women? Clin Chem 2003; 49:1201-1204.
8. Lin JP, Cupples LA, Wilson PW, Heard-Costa N, O'Donnell CJ. Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: a genomewide scan in the Framingham study. Am J Hum Genet 2003; 72:1029-1034.
9. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006; 114:1476-1481.
10. Gajdos V, Petit FM, Perret C, Mollet-Boudjemline A, Colin P, Capel L, et al. Further evidence that the UGT1A1 *28 allele is not associated with coronary heart disease: the ECTIM Study. Clin Chem 2006; 52:2313-2314.
11. Bosma PJ, van der Meer IM, Bakker CT, Hofman A, Paul-Abrahamse M, Witteman JC. UGT1A1 *28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003; 49:1180-1181.
12. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vase Biol 2002; 22:1680-1685.
13. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, el al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111:1-8.
14. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, et al. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 2004; 91:155-161.
15. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004; 173:315-319.
16. Ahmad Z, Salim M, Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J Biol Chem 2002; 277:9226-9232.
17. Kravets A, Hu Z, Miralem T, Torno MD, Maines MD. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. J Biol Chem 2004; 279:19916-19923.
18. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002; 99:16093-16098.
19. Lemer-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci U S A 2005; 102:7109-7114.
20. LeWinter MM. Association of syndromes of insulin resistance with coronary artery disease. Coron Artery Dis 2005; 16:477-480.
21. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001; 276:9626-9630.
22. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 1999; 274:17159-17163.
23. Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 2003; 26:569-573.
24. Bastenie PA, Vanhaelst L, Bonnyns M, Neve P, Staquet M. Preclinical hypothyroidism: a risk factor for coronary heart-disease. Lancet 1971; 1:203-204.
25. Allen S, Dashwood M, Morrison K, Yacoub M. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. Circulation 1998; 97:2406-2413.
26. Allen SP, Dashwood MR, Chester AH, Tadjkarimi S, Collins M, Piper PJ, et al. Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotriene C4. Cardioscience 1993; 4:47-54.
27. Takase B, Kurita A, Maruyama T, Uehata A, Nishioka T, Mizuno K, et al. Change of plasma leukotriene C4 during myocardial ischemia in humans. Clin Cardiol 1996; 19:198-204.
28. Connolly E, Bouchier-Hayes DJ, Kaye E, Leahy A, Fitzgerald D, Belton O. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. J Pharmacol Exp Ther 2002; 300:393-398.
29. Kim MP, Gaydos CA, Wood BJ, Hardick JP, Zhang Y, Wahl LM. Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism. Infect Immun 2005; 73:632-634.
30. Kim MP, Zhou M, Wahl LM. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J Leukoc Biol 2005; 78:195-201.
31. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002; 64:635-661.
32. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, Deboer A, Oostra BA, et al. The Genetic-Basis of the Reduced Expression of Bilirubin Udp- Glucuronosyltransferase-1 in Gilberts-Syndrome. W Engl J Med 1995; 333:1171-1175.
33. Sole X, Guino E, Vails J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22:1928-1929.
34. Saeki M, Saito Y, Sai K, Maekawa K, Kaniwa N, Sawada J, et al. A combinatorial haplotype of the UDP-glucuronosyltransferase 1A1 gene (60-B) increases total bilirubin concentrations in Japanese volunteers. Clin Chem 2007; 53:356-358.
35. Novotny L, Vitek L Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003; 228:568-571.
36. Zhang A, Xing Q, Qin S, Du J, Wang L, Yu L, et al. Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations. Pharmacogenomics J 2007; 7:333-338.
37. Walden CE, Knopp RH, Johnson JL, Heiss G, Wahl PW, Hoover JJ. Effect of estrogen/progestin potency on clinical chemistry measures. The Lipid Research Clinics Program Prevalence Study. Am J Epidemiol 1986; 123:517-531.
38. Buckley DB, Klaassen CD. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 2007; 35:121-127.
39. Muraca M, Fevery J. Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. Gastroenterology 1984; 87:308-313.
40. Freeman R. Hormone replacement therapy (estrogen and progesterone): is it necessary for heart disease prevention? Prev Cardiol 2000, 3: 21-23.
41. McCarthy JJ. Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. Nutr Metab Cardiovasc Dis 2007; 17:153-161.
42. Hauser ER, Crossman DC, Granger CB, Haines JL, Jones CJ, Mooser V, et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004; 75: 436-447.
43. Turner ST, Peyser PA, Kardia SL, Bielak LF, Sheedy PF III, Boerwinkle E, et al. Genomic loci with pleiotropic effects on coronary artery calcification. Atherosclerosis 2006; 185:340-346.
44. Lin JP. Genome-wide scan on plasma triglyceride and high density lipoprotein cholesterol levels, accounting for the effects of correlated quantitative phenotypes. BMC Genet 2003; 4 (Suppl 1):S47.